{
  "symbol": "BIOCON.NS",
  "period": "annual",
  "data": [
    {
      "ticker": "BIOCON.NS",
      "date": "2021-03-31",
      "quarter": "Q1 2021",
      "fiscal_year": 2021,
      "revenue": null,
      "gross_profit": null,
      "operating_income": null,
      "ebitda": null,
      "net_income": null,
      "diluted_eps": null,
      "total_assets": null,
      "total_liabilities": null,
      "total_equity": null,
      "total_debt": null,
      "cash_and_equivalents": null,
      "current_assets": null,
      "current_liabilities": null,
      "operating_cash_flow": null,
      "investing_cash_flow": null,
      "financing_cash_flow": null,
      "free_cash_flow": null,
      "capex": null,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": null,
      "current_ratio": null,
      "operating_margin": null,
      "net_profit_margin": null,
      "roe": null,
      "roa": null,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": null
    },
    {
      "ticker": "BIOCON.NS",
      "date": "2022-03-31",
      "quarter": "Q1 2022",
      "fiscal_year": 2022,
      "revenue": 80248000000.0,
      "gross_profit": 53012000000.0,
      "operating_income": 11865000000.0,
      "ebitda": 18649000000.0,
      "net_income": 6484000000.0,
      "diluted_eps": null,
      "total_assets": 203940000000.0,
      "total_liabilities": 109240000000.0,
      "total_equity": 94700000000.0,
      "total_debt": 51466000000.0,
      "cash_and_equivalents": 6626000000.0,
      "current_assets": 83823000000.0,
      "current_liabilities": 38280000000.0,
      "operating_cash_flow": 11766000000.0,
      "investing_cash_flow": -16991000000.0,
      "financing_cash_flow": 2421000000.0,
      "free_cash_flow": -7482000000.0,
      "capex": -19248000000.0,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": 0.5434635691657866,
      "current_ratio": 2.189733542319749,
      "operating_margin": 14.785415212840194,
      "net_profit_margin": 8.079952148340146,
      "roe": 6.84688489968321,
      "roa": 3.1793664803373543,
      "debt_to_fcf_ratio": null,
      "ebitda_margin": 23.239208453793243
    },
    {
      "ticker": "BIOCON.NS",
      "date": "2023-03-31",
      "quarter": "Q1 2023",
      "fiscal_year": 2023,
      "revenue": 109341000000.0,
      "gross_profit": 72673000000.0,
      "operating_income": 16271000000.0,
      "ebitda": 24292000000.0,
      "net_income": 4627000000.0,
      "diluted_eps": null,
      "total_assets": 520428000000.0,
      "total_liabilities": 295540000000.0,
      "total_equity": 224888000000.0,
      "total_debt": 180188000000.0,
      "cash_and_equivalents": 13232000000.0,
      "current_assets": 123340000000.0,
      "current_liabilities": 85107000000.0,
      "operating_cash_flow": 18525000000.0,
      "investing_cash_flow": -142818000000.0,
      "financing_cash_flow": 130487000000.0,
      "free_cash_flow": 1262000000.0,
      "capex": -17263000000.0,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": 0.8012343922307993,
      "current_ratio": 1.4492344930499255,
      "operating_margin": 14.880968712559788,
      "net_profit_margin": 4.231715458976962,
      "roe": 2.057468606595283,
      "roa": 0.8890759144396534,
      "debt_to_fcf_ratio": 142.7797147385103,
      "ebitda_margin": 22.216734802132777
    },
    {
      "ticker": "BIOCON.NS",
      "date": "2024-03-31",
      "quarter": "Q1 2024",
      "fiscal_year": 2024,
      "revenue": 141958000000.0,
      "gross_profit": 92892000000.0,
      "operating_income": 14345000000.0,
      "ebitda": 40684000000.0,
      "net_income": 10225000000.0,
      "diluted_eps": null,
      "total_assets": 560707000000.0,
      "total_liabilities": 307959000000.0,
      "total_equity": 252748000000.0,
      "total_debt": 162767000000.0,
      "cash_and_equivalents": 12334000000.0,
      "current_assets": 151792000000.0,
      "current_liabilities": 153588000000.0,
      "operating_cash_flow": 29539000000.0,
      "investing_cash_flow": -10045000000.0,
      "financing_cash_flow": -23327000000.0,
      "free_cash_flow": 10223000000.0,
      "capex": -19316000000.0,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": 0.6439892699447671,
      "current_ratio": 0.9883063781024559,
      "operating_margin": 10.105101508896999,
      "net_profit_margin": 7.202834641231913,
      "roe": 4.045531517558992,
      "roa": 1.8235905740431275,
      "debt_to_fcf_ratio": 15.921647265968893,
      "ebitda_margin": 28.65918088448696
    },
    {
      "ticker": "BIOCON.NS",
      "date": "2025-03-31",
      "quarter": "Q1 2025",
      "fiscal_year": 2025,
      "revenue": 150522000000.0,
      "gross_profit": 98542000000.0,
      "operating_income": 16259000000.0,
      "ebitda": 44613000000.0,
      "net_income": 10133000000.0,
      "diluted_eps": null,
      "total_assets": 587973000000.0,
      "total_liabilities": 310848000000.0,
      "total_equity": 277125000000.0,
      "total_debt": 183620000000.0,
      "cash_and_equivalents": 32267000000.0,
      "current_assets": 162862000000.0,
      "current_liabilities": 143338000000.0,
      "operating_cash_flow": 40612000000.0,
      "investing_cash_flow": -2341000000.0,
      "financing_cash_flow": -18540000000.0,
      "free_cash_flow": 17179000000.0,
      "capex": -23433000000.0,
      "pe_ratio": 99.887215,
      "peg_ratio": null,
      "pb_ratio": 1.9037132,
      "ps_ratio": 3.229552,
      "price_target_high": 580.0,
      "price_target_low": 290.0,
      "price_target_avg": 415.35,
      "promoter_holding": 0.54889,
      "institutional_holding": 0,
      "eps_estimate": null,
      "dividends": 0.5,
      "splits": 2.0,
      "buybacks": 1335075994,
      "debt_to_equity": 0.6625890843482183,
      "current_ratio": 1.1362095187598544,
      "operating_margin": 10.801743266764992,
      "net_profit_margin": 6.731906299411381,
      "roe": 3.656472710870546,
      "roa": 1.7233784544528403,
      "debt_to_fcf_ratio": 10.688631468653588,
      "ebitda_margin": 29.638856778411128
    }
  ]
}